Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Mar 31, 2015

Filed with the SEC on May 20, 2015 and accepted by EDGAR at May 20, 2015, 20:46 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-01-01 to 2015-03-31$113us-gaap:SalesRevenueNet
Operating income3 months2015-01-01 to 2015-03-31−$9.8kus-gaap:OperatingIncomeLoss
Net income3 months2015-01-01 to 2015-03-31−$11.6kus-gaap:NetIncomeLoss
Diluted EPS3 months2015-01-01 to 2015-03-31$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2015-01-01 to 2015-03-31−$19.6kus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash and equivalentsAt period end2015-03-31$195us-gaap:Cash
Current assetsAt period end2015-03-31$195us-gaap:AssetsCurrent
Total assetsAt period end2015-03-31$195us-gaap:Assets
Current liabilitiesAt period end2015-03-31$35.2kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-03-31$35.2kus-gaap:Liabilities
Shareholders' equityAt period end2015-03-31−$35.0kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-15-032615. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.